The Patent Finder

Terms ending in 2031

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,754,072Salts and Polymorphs of 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 9,045,487Salts and Polymorphs of 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 9,861,638Salts and Polymorphs of 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
In force
 · Low confidence
Pfizer Inc.In forceLow confidence
US 10,278,974Salts and Polymorphs of 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
In force
 · Low confidence
Pfizer Inc.In forceLow confidence
US 8,722,884Pyrimidine Derivatives for the Treatment of Abnormal Cell Growth
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 9,119,839Cancer Treatment
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 9,326,945Apixaban Formulations
In force
 · High confidence
Bristol-Myers Squibb Company and Pfizer Inc.In forceHigh confidence
US 8,580,268CPG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 8,278,457Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof
In force
 · High confidence
Biogen Ma Inc.In forceHigh confidence
US 9,012,369Look-Through Mutagenesis for Developing Altered Polypeptides with Enhanced Properties
In force
 · High confidence
Pfizer, Inc.In forceHigh confidence
10 more term ends in 2031 · Pro
10 of 20 patents shown. Soonest term end first, then patent number.
Pro members see all 20.
Upgrade to Pro
17 of these are in force and held by Pfizer Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited